Provided by Tiger Trade Technology Pte. Ltd.

Oppenheimer

86.35
+0.95001.11%
Volume:37.86K
Turnover:3.27M
Market Cap:924.57M
PE:6.62
High:87.27
Open:85.84
Low:85.06
Close:85.40
52wk High:94.10
52wk Low:49.26
Shares:10.71M
Float Shares:5.93M
Volume Ratio:0.84
T/O Rate:0.64%
Dividend:0.72
Dividend Rate:0.83%
EPS(TTM):13.04
EPS(LYR):13.04
ROE:16.02%
ROA:4.16%
PB:0.94
PE(LYR):6.62

Loading ...

BridgeBio Oncology Therapeutics (BBOT) Gets a Buy from Oppenheimer

TIPRANKS
·
Mar 06

Oppenheimer Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Mar 06

Oppenheimer Sticks to Their Buy Rating for Mediwound (MDWD)

TIPRANKS
·
Mar 06

Caterpillar price target raised to $817 from $729 at Oppenheimer

TIPRANKS
·
Mar 06

ArriVent Biopharma price target raised to $50 from $44 at Oppenheimer

TIPRANKS
·
Mar 06

Oppenheimer Initiates Coverage on Motorcar Parts of America With Outperform Rating, $18 Price Target

MT Newswires Live
·
Mar 06

Motorcar Parts of Amer Initiated at Outperform by Oppenheimer

Dow Jones
·
Mar 06

Gossamer Bio Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Mar 06

Lennox Offers 'Clear' Playbook for Growth, Oppenheimer Says

MT Newswires Live
·
Mar 06

Theravance Biopharma downgraded at Oppenheimer after ampreloxetine miss

TIPRANKS
·
Mar 05

Oppenheimer Adjusts Genius Sports PT to $11 From $12, Maintains Outperform Rating

MT Newswires Live
·
Mar 05

Oppenheimer Sticks to Its Buy Rating for StubHub Holdings Incorporation Class A (STUB)

TIPRANKS
·
Mar 05

Lennox International (LII) Gets a Buy from Oppenheimer

TIPRANKS
·
Mar 05

Target's Prospects Likely to Improve as Turnaround Efforts Take Shape, Oppenheimer Says

MT Newswires Live
·
Mar 05

Blue Owl's Negative Press May Weigh on Near-Term Fundraising, Valuation, Oppenheimer Says

MT Newswires Live
·
Mar 04

Oppenheimer Adjusts Target PT to $140 From $130, Maintains Outperform Rating

MT Newswires Live
·
Mar 04

Oppenheimer Adjusts Price Target on PACS Group to $42 From $40, Maintains Outperform Rating

MT Newswires Live
·
Mar 04

Oppenheimer Adjusts Price Target on NerdWallet to $15 From $18, Maintains Outperform Rating

MT Newswires Live
·
Mar 04

Oppenheimer Adjusts Price Target on Blue Owl Capital to $17 From $24, Maintains Outperform Rating

MT Newswires Live
·
Mar 04

PACS Group Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Mar 04